HealthEquity Inc. (HQY)
Here's Why HealthEquity (HQY) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
HealthEquity Stock Falls Despite Q3 Earnings and Revenue Beat
HQY's fiscal third-quarter results benefit from robust HSA growth and improved gross margin. It also raises fiscal 2025 guidance.
HealthEquity Stock Falls on Disappointing Outlook
Shares of HealthEquity (HQY) tumbled Tuesday after the health savings account (HSA) custodian's full-year outlook missed forecasts.
HealthEquity, Inc. (HQY) Q3 2025 Earnings Call Transcript
HealthEquity, Inc. (NASDAQ:HQY ) Q3 2025 Earnings Conference Call December 9, 2024 4:30 PM ET Company Participants Richard Putnam - IR Jon Kessler - President and CEO James Lucania - EVP and CFO Steve Neeleman - Vice Chair and Founder Scott Cutler - upcoming President and CEO Conference Call Participants Gregory Peters - Raymond James Stan Berenshteyn - Wells Fargo Glen Santangelo - Jefferies Allen Lutz - Bank of America Anne Samuel - JPMorgan George Hill - Deutsche Bank Mark Marcon - Baird David Roman - Goldman Sachs David Larsen - BTIG Steven Valiquette - Mizuho Securities Sean Dodge - RBC Capital Markets Operator Good afternoon, and welcome to the HealthEquity Third Quarter 2025 Earnings Conference Call. Please note this event is being recorded.
HealthEquity (HQY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended October 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
HealthEquity (HQY) Beats Q3 Earnings and Revenue Estimates
HealthEquity (HQY) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.60 per share a year ago.
Unlocking Q3 Potential of HealthEquity (HQY): Exploring Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for HealthEquity (HQY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2024.
HealthEquity, Inc. (HQY) Hit a 52 Week High, Can the Run Continue?
HealthEquity (HQY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
HealthEquity Gains 54.6% YTD: What's Driving the Stock?
HQY's sustained strength in HSAs raises optimism about the stock.
HealthEquity: High Marks For Recent Profit Growth
HealthEquity's future growth relies heavily on capital reinvestment due to the asset-light nature of the business. High multiples of capital are necessary to ensure each $1 of retained and reinvested earnings is valued highly by the market. The core asset base has hard-to-replicate business advantages that have grown operating earnings at attractive rates which by all means can continue.
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Strength Seen in HealthEquity (HQY): Can Its 3.5% Jump Turn into More Strength?
HealthEquity (HQY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
